Phibro Animal Health | PAHC - Interest Expense On Debt

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $8.76M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Align Technology USD 2M 660K Mar/2023
ANI Pharmaceuticals USD 4.73M 711K Sep/2025
Assertio Holdings USD 758K 1000 Jun/2024
Aurora Cannabis CAD 2.22M 442K Sep/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Canopy Growth CAD 8.8M 938K Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Henry Schein USD 38M 0 Sep/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Merck USD 412M 85M Dec/2025
Nektar Therapeutics USD 6.02M 420K Sep/2024
Pacira USD 4.28M 456K Sep/2025
Phibro Animal Health USD 8.76M 2.76M Sep/2024
Prestige Brands USD 10.67M 636K Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Zoetis USD 57M 1000K Dec/2025